VIEWPOINTNew approach for recruitment into randomised controlled trials
References (7)
Assessing the effects of health technologies: principles, practice, proposals
(1992)AIDS, ethics, and clinical trials
BMJ
(1992)AIDS, activism and the politics of health
N Engl J Med
(1992)
Cited by (50)
Impact of a cancer clinical trials web site on discussions about trial participation: A cluster randomized trial
2012, Annals of OncologyCitation Excerpt :The scores are comparable with other published studies and are consistent with poor knowledge about randomized clinical trials [20, 24]. In 1993, Baum called for a way to better inform people about randomized trials and it is clear that > 15 years later public and patient education is urgently required [27]. The mean decision conflict score was similar in both groups.
Clinical trials - A brave new partnership: A new doctor-patient working relationship in research
2008, International Journal of SurgeryCitation Excerpt :He relished dissent within the scientific process, for, as he said, “without dissent there can be no progress.” He pushed the boundaries with his 1993 Lancet paper “new approach for recruitment to randomised trials”17: this was met with excitement in my editorial commentary, but also with robust challenge.18 It led on to organised, productive, brave new partnerships in research, not just in breast cancer,19 but also generally.
Barriers to participation in clinical trials of cancer: A meta-analysis and systematic review of patient-reported factors
2006, Lancet OncologyCitation Excerpt :Although the balance between societal benefits and individual patient benefits must be recognised, it seems appropriate to stress in particular the advances from clinical research with individual participants and the communities in which these studies are done.25,26 This contentious issue for ethicists and trialists is one that an institutional review board should be aware of because some critics have construed the potential societal benefit as coercion.44 In addition to the aim of easing participant anxieties, an approach that focuses on the individual patient might negate concerns related to mistrust of the scientific community and the research process in general.45
Tamoxifen beyond 5 years - Patients' decisions regarding entry to the aTTom trial
2002, European Journal of Cancer